Shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $37.5833.
Several brokerages have commented on OPCH. Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Tuesday, January 13th. Bank of America raised their target price on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $38.00 price target (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft increased their price target on Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Finally, TD Cowen reissued a “hold” rating on shares of Option Care Health in a report on Tuesday, January 27th.
Read Our Latest Research Report on Option Care Health
Option Care Health Trading Up 0.1%
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of OPCH. V Square Quantitative Management LLC purchased a new stake in Option Care Health during the fourth quarter worth $25,000. Cornerstone Planning Group LLC raised its position in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. Advisory Services Network LLC purchased a new stake in shares of Option Care Health during the 3rd quarter worth about $35,000. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the 2nd quarter valued at about $37,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Option Care Health in the 3rd quarter valued at about $38,000. 98.05% of the stock is owned by institutional investors and hedge funds.
Option Care Health Company Profile
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Read More
- Five stocks we like better than Option Care Health
- Elon Musk already made me a “wealthy man”
- America’s 1776 happening again
- [How To] Invest Pre-IPO In SpaceX With $100!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
